3D Bioprinting Market Size, Share & Trends Analysis Report By Technology (Magnetic Levitation, Inkjet-based, Syringe-based, Laser-based), By Application (Medical, Dental, Biosensors, Bioinks), And Segment Forecasts, 2019 - 2026

Industry Insights

The global 3D bioprinting market size was valued at USD 965.0 million in 2018 and is expected to witness a CAGR of 19.5% over the forecast period. This growth is attributed to the rising incidence of chronic diseases, such as heart and kidney failures, increasing aging population, and limited number of organ donors. Advancements in technology & IT within the healthcare industry and rising R&D investments are also likely to boost the market growth.

For instance, in January 2019, The Institute for Technology Inspired Regenerative Medicine in Netherlands collaborated with Aspect Biosystems, a Canadian company, for the advancements in 3D printing and regenerative medicine. As of 2018, numerous universities and research institutes have invested in the development of highly efficient and better quality bio-implants at low costs.

For instance, 3D bioprinting using graphene, which has high strength than plastic and is highly comfortable and durable. In the recent past, the University of Plymouth with support from Agri-tech Cornwall Project developed skin substitute, which is similar to human skin. The 3D bio-printer is using nanotechnology, which is used to print live skin-based organs within hours. Increasing prevalence of cancer is also one of the key factors boosting the market growth.

For instance, 3D bioprinting of the bio-mimetic microstructure is used for the cancer cell migration studies. Increasing geriatric population base, which is highly susceptible to neurological diseases, cancer, cardiac conditions, and spinal injuries is also expected to contribute to the industry expansion further over the forecast period. In addition, innovations, in terms of technologies and products, shaping the future of the global industry will augment the growth in the years to come.

Technology Insights

On the basis of technology, the market is segmented into magnetic levitation, laser-based, inkjet-based, syringe-based, and other 3D bioprinting. Magnetic levitation segment is anticipated to witness the fastest growth over the forecast period, while syringe-based segment is projected to have the largest market share. The broad application area and rise in the adoption of the technique by innovators is a vital factor that promotes the growth of magnetic levitation.

Furthermore, the products based on the same principle are mostly cost-efficient, hence boosts market growth. 3D bio-printers based on magnetic levitation are anticipated to solve more than 80.0% of the current failures with enhanced speed, features, and precision. These bio-printers find application in vascular muscles printing, toxicity screening, and human cell regeneration. For instance, BioAssay develops tissue-like structure, which uses magnetic levitation-based devices.

Application Insights

On the basis of application, the market has been segmented into dental, biosensors, bioinks, medical, food and animal product bioprinting, and consumer/personal product testing. The medical segment is further segmented into tissue and organ generation, prosthetic and implants, and medical pills. The segment is anticipated to have a market share of over 38.0% by 2026.The medical pill is the latest development in the market and is anticipated to witness high growth over the forecast period.

Increasing need for the medicines and advantage of fast and cost-efficient production of bio-drugs using this technology are driving the segment further. The pharmaceutical industry is expected to grow multi-fold, thereby increasing the demand for medical pills. For instance, in March 2016, Aprecia Pharmaceuticals, a U.S.-based pharma company, received the first-ever USFDA approval for the 3D printing for the drug Spritam. The drug has therapeutic action in the treatment of epileptic patients.

Regional Insights

North America is projected to be the dominant regional market over the forecast period. Increasing target population base is expected to be the key factor augmenting the region’s growth. The presence of well-established companies and sophisticated healthcare infrastructure along with high disposable income levels in the region are also expected people the market growth. Furthermore, extensive research activities conducted within the region are said to contribute to the market expansion.

In October 2018, the U.S. FDA awarded a grant of USD 2.5 million to top five research institutions for R&D in bio-manufacturing, including 3D bioprinting. It included Harvard University, Carnegie Mellon University, Rutgers University, Georgia Institute of Technology, and Massachusetts Institute of Technology. The Asia Pacific regional market is expected to witness the highest CAGR over the forecast period.

Presence of the target population and quick adoption of innovations in the regional market are expected to be the prime factors responsible for this growth. Moreover, rising awareness about 3D printing technology, increasing foreign investments, and favorable government policies are further expected to impel the growth. For instance, China introduced “Made in China 2025” initiative to foster advanced technology in the 3D printing space. Moreover, China’s Ministry of Industry and Information Technology released dedicated plan for the commercialization of the industry.

3D Bioprinting Market Share Insights

Key players in the global market include Organovo Holding, Inc.; Luxexcel Group B.V.; TeVido BioDevices, LLC; 3Dynamics Systems Ltd.; Cyfuse Biomedical K.K.; Aspect Biosystems Ltd.; Stratasys Ltd.; Voxeljet A.G.; Bio3D Technologies Pte. Ltd.; Materialise N.V.; Envision TEC; and Solidscape, Inc. (acquired by Prodways Group).

Most of these companies have tie-ups with research institutes and universities that work on grafting and organ regeneration technologies. Companies are also scheduling various exhibitions and seminars to raise awareness about the technology globally. Organovo Holding, Inc. announced a partnership with hair and skin care L’Oreal for the development of skin tissue with its NovoGen Bioprinting Platform.

Report Scope

Segments Covered in the Report

This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2026. For the purpose of this study, Grand View Research has segmented the global 3D bioprinting market report on the basis of technology, application, and region:

• Technology Outlook (Revenue, USD Million, 2015 - 2026)

  • Magnetic Levitation

  • Inkjet-based

  • Syringe-based

  • Laser-based

  • Others

• Application Outlook (Revenue, USD Million, 2015 - 2026)

  • Medical

    • Tissue and Organ Generation

    • Medical Pills

    • Prosthetic and Implants

  • Dental

  • Biosensors

  • Consumer/Personal Product Testing

  • Bioinks

  • Food and Animal Product

• Regional Outlook (Revenue, USD Million, 2015 - 2026)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE